| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 2.109 | 31.027 | 24.056 |
| Total Income - EUR | - | - | - | - | - | - | - | 2.109 | 31.027 | 24.056 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 585 | 10.633 | 13.147 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 1.524 | 20.394 | 10.908 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 1.503 | 20.082 | 10.667 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Sinalexmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 45 | 1.640 | 1.142 |
| Current Assets | - | - | - | - | - | - | - | 2.049 | 21.359 | 10.637 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 71 | 15.910 | 1.216 |
| Cash | - | - | - | - | - | - | - | 1.978 | 5.449 | 9.421 |
| Shareholders Funds | - | - | - | - | - | - | - | 1.544 | 21.621 | 10.716 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 550 | 1.379 | 1.063 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Sinalexmed S.r.l.